News on Biovitrum from BioPortfolio.com http://www.BioPortfolio.com Consolidated Biovitrum news from BioPortfolio.com Wed, 10 Feb 2010 08:55:34 GMT en First Patient Dosed in Hemophilia B Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004373&HITNO=0&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004373&THISHREF=http://c.moreover.com/click/here.pl%3fz2519924563%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004373&HITNO=0&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004373&THISHREF=http://c.moreover.com/click/here.pl%3fz2519924563%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Discovery World: Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Ahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981353&HITNO=1&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981353&THISHREF=http://c.moreover.com/click/here.pl%3fz2506932595%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981353&HITNO=1&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981353&THISHREF=http://c.moreover.com/click/here.pl%3fz2506932595%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Merger of Biovitrum and Swedish Orphanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962453&HITNO=2&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962453&THISHREF=http://c.moreover.com/click/here.pl%3fz2497281083%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962453&HITNO=2&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962453&THISHREF=http://c.moreover.com/click/here.pl%3fz2497281083%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Trial of Long-Acting Hemophilia B Thehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962458&HITNO=3&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962458&THISHREF=http://c.moreover.com/click/here.pl%3fz2497283282%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962458&HITNO=3&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962458&THISHREF=http://c.moreover.com/click/here.pl%3fz2497283282%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: Biogen Idec, Orphan Biovitrum partner for hemophilia B drug trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3963607&HITNO=4&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3963607&THISHREF=http://c.moreover.com/click/here.pl%3fz2497795180%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3963607&HITNO=4&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3963607&THISHREF=http://c.moreover.com/click/here.pl%3fz2497795180%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960950&HITNO=5&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960950&THISHREF=http://c.moreover.com/click/here.pl%3fz2496520742%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960950&HITNO=5&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960950&THISHREF=http://c.moreover.com/click/here.pl%3fz2496520742%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR-Canada.net: Biogen Kicks Off Haemophilia B Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962773&HITNO=6&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962773&THISHREF=http://c.moreover.com/click/here.pl%3fz2497461231%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962773&HITNO=6&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962773&THISHREF=http://c.moreover.com/click/here.pl%3fz2497461231%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: Biogen Kicks off Haemophilia B Trialshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962464&HITNO=7&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962464&THISHREF=http://c.moreover.com/click/here.pl%3fz2497291397%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962464&HITNO=7&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962464&THISHREF=http://c.moreover.com/click/here.pl%3fz2497291397%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Ahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955450&HITNO=8&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955450&THISHREF=http://c.moreover.com/click/here.pl%3fz2494035661%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955450&HITNO=8&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955450&THISHREF=http://c.moreover.com/click/here.pl%3fz2494035661%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: Biogen Idec And Swedish Orphan Biovitrum Announce First Patient Dosed In Global Registrational Trial Of Long-Ahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958764&HITNO=9&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958764&THISHREF=http://c.moreover.com/click/here.pl%3fz2495513001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958764&HITNO=9&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958764&THISHREF=http://c.moreover.com/click/here.pl%3fz2495513001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMediLexicon: Biogen Idec, Swedish Orphan Biovitrum Initiate Dosing In Hemophilia B Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956295&HITNO=10&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956295&THISHREF=http://c.moreover.com/click/here.pl%3fz2494483801%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956295&HITNO=10&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956295&THISHREF=http://c.moreover.com/click/here.pl%3fz2494483801%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Business Review: Biovitrum (SE) - Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrationahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957690&HITNO=11&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957690&THISHREF=http://c.moreover.com/click/here.pl%3fz2495053327%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957690&HITNO=11&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957690&THISHREF=http://c.moreover.com/click/here.pl%3fz2495053327%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Medical News: Biogen Idec And Swedish Orphan Biovitrum Announce First Patient Dosed In Global Registrational Trial Of Long-Acting Hemophilia B Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957111&HITNO=12&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957111&THISHREF=http://c.moreover.com/click/here.pl%3fz2494839501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957111&HITNO=12&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957111&THISHREF=http://c.moreover.com/click/here.pl%3fz2494839501%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Acting Hemophilia B Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955494&HITNO=13&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955494&THISHREF=http://c.moreover.com/click/here.pl%3fz2494053717%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955494&HITNO=13&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955494&THISHREF=http://c.moreover.com/click/here.pl%3fz2494053717%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Acting Hemophilia B Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955492&HITNO=14&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955492&THISHREF=http://c.moreover.com/click/here.pl%3fz2494053078%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955492&HITNO=14&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Biovitrum&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955492&THISHREF=http://c.moreover.com/click/here.pl%3fz2494053078%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: